255 related articles for article (PubMed ID: 9746908)
21. Presenilin-1 affects trafficking and processing of betaAPP and is targeted in a complex with nicastrin to the plasma membrane.
Kaether C; Lammich S; Edbauer D; Ertl M; Rietdorf J; Capell A; Steiner H; Haass C
J Cell Biol; 2002 Aug; 158(3):551-61. PubMed ID: 12147673
[TBL] [Abstract][Full Text] [Related]
22. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity.
Wolfe MS; Xia W; Ostaszewski BL; Diehl TS; Kimberly WT; Selkoe DJ
Nature; 1999 Apr; 398(6727):513-7. PubMed ID: 10206644
[TBL] [Abstract][Full Text] [Related]
23. PS1 N- and C-terminal fragments form a complex that functions in APP processing and Notch signaling.
Levitan D; Lee J; Song L; Manning R; Wong G; Parker E; Zhang L
Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12186-90. PubMed ID: 11593035
[TBL] [Abstract][Full Text] [Related]
24. Co-expressed presenilin 1 NTF and CTF form functional gamma-secretase complexes in cells devoid of full-length protein.
Laudon H; Mathews PM; Karlström H; Bergman A; Farmery MR; Nixon RA; Winblad B; Gandy SE; Lendahl U; Lundkvist J; Näslund J
J Neurochem; 2004 Apr; 89(1):44-53. PubMed ID: 15030388
[TBL] [Abstract][Full Text] [Related]
25. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
26. [Beta-amyloid protein: recent progress in basic research and therapeutic approaches].
Iwatsubo T
Rinsho Shinkeigaku; 2001 Dec; 41(12):1198-200. PubMed ID: 12235837
[TBL] [Abstract][Full Text] [Related]
27. Mapping the APP/presenilin (PS) binding domains: the hydrophilic N-terminus of PS2 is sufficient for interaction with APP and can displace APP/PS1 interaction.
Pradier L; Carpentier N; Delalonde L; Clavel N; Bock MD; Buée L; Mercken L; Tocqué B; Czech C
Neurobiol Dis; 1999 Feb; 6(1):43-55. PubMed ID: 10078972
[TBL] [Abstract][Full Text] [Related]
28. [Advances in molecular biology and clinical study of amyloid precursor protein for Alzheimer's disease].
Xu BG; Wu X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):201-9. PubMed ID: 15171563
[TBL] [Abstract][Full Text] [Related]
29. Generation of amyloid beta protein from a presenilin-1 and betaAPP complex.
Shizuka-Ikeda M; Matsubara E; Ikeda M; Kanai M; Tomidokoro Y; Ikeda Y; Watanabe M; Kawarabayashi T; Harigaya Y; Okamoto K; Maruyama K; Castaño EM; St George-Hyslop P; Shoji M
Biochem Biophys Res Commun; 2002 Mar; 292(2):571-8. PubMed ID: 11906199
[TBL] [Abstract][Full Text] [Related]
30. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1.
Duff K; Eckman C; Zehr C; Yu X; Prada CM; Perez-tur J; Hutton M; Buee L; Harigaya Y; Yager D; Morgan D; Gordon MN; Holcomb L; Refolo L; Zenk B; Hardy J; Younkin S
Nature; 1996 Oct; 383(6602):710-3. PubMed ID: 8878479
[TBL] [Abstract][Full Text] [Related]
31. Increased Abeta42(43) from cell lines expressing presenilin 1 mutations.
Mehta ND; Refolo LM; Eckman C; Sanders S; Yager D; Perez-Tur J; Younkin S; Duff K; Hardy J; Hutton M
Ann Neurol; 1998 Feb; 43(2):256-8. PubMed ID: 9485068
[TBL] [Abstract][Full Text] [Related]
32. Presenilins and Alzheimer's disease: the role of A beta 42.
Eckman CB
J Neural Transm Suppl; 1998; 53():181-4. PubMed ID: 9700656
[TBL] [Abstract][Full Text] [Related]
33. Presenilin 1 binds to amyloid precursor protein directly.
Waragai M; Imafuku I; Takeuchi S; Kanazawa I; Oyama F; Udagawa Y; Kawabata M; Okazawa H
Biochem Biophys Res Commun; 1997 Oct; 239(2):480-2. PubMed ID: 9344855
[TBL] [Abstract][Full Text] [Related]
34. beta-Amyloid, protein processing and Alzheimer's disease.
Haas C; Hung AY; Citron M; Teplow DB; Selkoe DJ
Arzneimittelforschung; 1995 Mar; 45(3A):398-402. PubMed ID: 7763333
[TBL] [Abstract][Full Text] [Related]
35. Increase in p53 protein levels by presenilin 1 gene mutations and its inhibition by secretase inhibitors.
Ma L; Ohyagi Y; Miyoshi K; Sakae N; Motomura K; Taniwaki T; Furuya H; Takeda K; Tabira T; Kira J
J Alzheimers Dis; 2009; 16(3):565-75. PubMed ID: 19276551
[TBL] [Abstract][Full Text] [Related]
36. [Biochemistry of presenilin 1].
Takashima A
Rinsho Shinkeigaku; 1997 Dec; 37(12):1097-8. PubMed ID: 9652956
[TBL] [Abstract][Full Text] [Related]
37. Familial Alzheimer's disease-linked mutations at Val717 of amyloid precursor protein are specific for the increased secretion of A beta 42(43).
Maruyama K; Tomita T; Shinozaki K; Kume H; Asada H; Saido TC; Ishiura S; Iwatsubo T; Obata K
Biochem Biophys Res Commun; 1996 Oct; 227(3):730-5. PubMed ID: 8886002
[TBL] [Abstract][Full Text] [Related]
38. Missense mutations associated with familial Alzheimer's disease in Sweden lead to the production of the amyloid peptide without internalization of its precursor.
Essalmani R; Macq AF; Mercken L; Octave JN
Biochem Biophys Res Commun; 1996 Jan; 218(1):89-96. PubMed ID: 8573182
[TBL] [Abstract][Full Text] [Related]
39. Stable association of presenilin derivatives and absence of presenilin interactions with APP.
Thinakaran G; Regard JB; Bouton CM; Harris CL; Price DL; Borchelt DR; Sisodia SS
Neurobiol Dis; 1998 Apr; 4(6):438-53. PubMed ID: 9666482
[TBL] [Abstract][Full Text] [Related]
40. A novel presenilin-1 mutation: increased beta-amyloid and neurofibrillary changes.
Gómez-Isla T; Wasco W; Pettingell WP; Gurubhagavatula S; Schmidt SD; Jondro PD; McNamara M; Rodes LA; DiBlasi T; Growdon WB; Seubert P; Schenk D; Growdon JH; Hyman BT; Tanzi RE
Ann Neurol; 1997 Jun; 41(6):809-13. PubMed ID: 9189043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
